Serina Therapeutics, Inc.

NYSEAM:SER Stock Report

Market Cap: US$49.1m

Serina Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSEAM:SER Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Dec 24BuyUS$17,745Gregory BaileyIndividual3,866US$4.59
20 Sep 24BuyUS$6,851Gregory BaileyIndividual1,137US$6.03
19 Sep 24BuyUS$88,257Gregory BaileyIndividual14,388US$6.23
12 Sep 24BuyUS$38,814Steven MintzIndividual6,000US$6.47
20 Aug 24BuyUS$14,652Gregory BaileyIndividual1,776US$8.25
19 Aug 24BuyUS$140,116Gregory BaileyIndividual19,200US$7.93
15 Aug 24BuyUS$58,928Steven MintzIndividual8,943US$6.59
14 Aug 24BuyUS$45,228Gregory BaileyIndividual6,400US$7.07
25 Jun 24BuyUS$70,900Steven MintzIndividual7,600US$9.50
30 May 24BuyUS$60,591Gregory BaileyIndividual6,378US$9.50
28 May 24BuyUS$85,681Gregory BaileyIndividual9,019US$9.50
23 May 24BuyUS$31,227Gregory BaileyIndividual3,287US$9.50
21 May 24BuyUS$13,509Gregory BaileyIndividual1,422US$9.50
21 May 24BuyUS$120,827Steven MintzIndividual12,380US$10.00
20 May 24BuyUS$900Gregory BaileyIndividual100US$9.00

Insider Trading Volume

Insider Buying: SER insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SER?
Owner TypeNumber of SharesOwnership Percentage
Institutions633,0906.74%
General Public2,477,36826.4%
Individual Insiders2,735,13229.1%
Private Companies3,546,38637.8%

Dilution of Shares: SER only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 73.62% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
28.1%
Juvenescence Ltd.
2,637,595US$13.8m16.3%no data
9.63%
Puffinus, Inc.
904,884US$4.7m0%no data
7.99%
Michael Bentley
750,000US$3.9m0%no data
7.54%
Helen McMillan
708,610US$3.7m0%no data
5.31%
Barbara Fisk
498,558US$2.6m0%no data
4.49%
Miguel Loya
422,101US$2.2m0%no data
2.66%
John Chenault
250,000US$1.3m0%no data
2.43%
Ki Partners LLC
227,927US$1.2m0%no data
2%
Broadwood Capital, Inc.
187,481US$980.5k120%0.07%
0.72%
Waverly Advisors, LLC
67,492US$353.0k187%0.01%
0.72%
Gregory Bailey
67,243US$351.7k6.1%no data
0.47%
The Vanguard Group, Inc.
44,500US$232.7k101%no data
0.41%
Steven Mintz
38,230US$199.9k0%no data
0.26%
Geode Capital Management, LLC
24,026US$125.7k5.62%no data
0.24%
HighTower Advisors, LLC
22,434US$117.3k-0.21%no data
0.21%
Millennium Management LLC
19,256US$100.7k-11.2%no data
0.19%
Keel Point, LLC
17,774US$93.0k0%0.01%
0.16%
Northern Trust Global Investments
14,787US$77.3k0%no data
0.042%
Emily M. Robertson Gst Trust
3,907US$20.4k0%no data
0.038%
BlackRock, Inc.
3,572US$18.7k-10.2%no data
0.031%
British & American Investment Trust PLC
2,902US$15.2k0%0.2%
0.0086%
Tower Research Capital Europe Limited
804US$4.2k-58.9%no data
0.0042%
Neal Bradsher
390US$2.0k0%no data
0.0003%
Piscataqua Savings Bank, Asset Management Arm
28US$147.40%no data
0.00026%
Bank of America Corporation, Asset Management Arm
24US$127.7-22.6%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 07:21
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Serina Therapeutics, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution